Earnings Yield: 8.61%
Is the earnings yield high or low?
The earnings yield of 8.61% is 16% below its 5-year average of 10.26%, near the low end of its 5-year range (3.84%–25.58%).
As of Saturday, June 27, 2026. 23.78% above its 12-month average of 6.96%.
GSK Earnings Yield Chart
GSK Average Earnings Yield Chart
GSK Current vs Average Earnings Yield Chart
GSK Earnings Yield Metrics
EARNINGS YIELD
8.61%
EARNINGS YIELD AVG TTM
6.96%
EARNINGS YIELD AVG 3Y
6.52%
EARNINGS YIELD AVG 5Y
6.91%
EARNINGS YIELD AVG 10Y
5.88%
EARNINGS YIELD AVG 15Y
6.28%
EARNINGS YIELD AVG 20Y
7.24%
CURRENT VS TTM AVG
+23.78%
CURRENT VS 3Y AVG
+32.08%
CURRENT VS 5Y AVG
+24.64%
CURRENT VS 10Y AVG
+46.49%
CURRENT VS 15Y AVG
+37.10%
CURRENT VS 20Y AVG
+18.93%
GSK Competitors' Earnings Yield
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GSK plc (GSK) | $105.20B | 8.61% | 6.96% | 6.52% | 6.91% |
| Medtronic plc (MDT)vs › | $103.66B | 4.61% | 4.00% | 3.74% | 3.63% |
| Bristol-Myers Squibb Company (BMY)vs › | $116.46B | 6.43% | 5.73% | 6.26% | 5.44% |
| McKesson Corporation (MCK)vs › | $89.39B | 5.04% | 3.90% | 4.24% | 4.12% |
| HCA Healthcare, Inc. (HCA)vs › | $86.89B | 7.42% | 5.94% | 6.43% | 7.09% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $124.70B | 3.43% | 3.42% | 3.43% | 3.71% |
| Elevance Health Inc. (ELV)vs › | $84.88B | 6.07% | 7.27% | 6.27% | 5.79% |
| Stryker Corporation (SYK)vs › | $127.39B | 2.60% | 2.24% | 2.33% | 2.29% |
| CVS Health Corp. (CVS)vs › | $133.13B | 2.18% | 2.74% | 5.87% | 5.66% |
| Cigna Corporation (CI)vs › | $74.81B | 8.34% | 7.49% | 5.82% | 6.71% |
Earnings Yield vs P/E Ratio
Earnings Yield
8.61%
EPS ÷ Price
P/E Ratio
11.6
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
- It expresses earnings relative to share price as a percentage
- It can be compared with FCF yield and dividend yield
- It can be compared with bond yields because both are percentages
- It is mathematically the inverse of the P/E ratio
Earnings Yield Formula & Definition
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Earnings Yield FAQ
- What is the earnings yield for GSK plc (GSK)?
- The earnings yield for GSK stock is 8.61%.
- Is GSK plc's earnings yield high or low?
- The earnings yield of 8.61% is 16% below its 5-year average of 10.26%, near the low end of its 5-year range (3.84%–25.58%).
- What is the TTM average earnings yield for GSK plc (GSK)?
- The TTM average earnings yield for GSK stock is 6.96%.
- What is the 3Y average earnings yield for GSK plc (GSK)?
- The 3Y average earnings yield for GSK stock is 6.52%.
- What is the 5Y average earnings yield for GSK plc (GSK)?
- The 5Y average earnings yield for GSK stock is 6.91%.
- What is the 10Y average earnings yield for GSK plc (GSK)?
- The 10Y average earnings yield for GSK stock is 5.88%.
- What is the 15Y average earnings yield for GSK plc (GSK)?
- The 15Y average earnings yield for GSK stock is 6.28%.
- What is the 20Y average earnings yield for GSK plc (GSK)?
- The 20Y average earnings yield for GSK stock is 7.24%.
GSK Earnings Yield History
| DATE | EARNINGS YIELD |
|---|---|
| 2026-06-26 | 8.61% |
| 2026-06-25 | 8.71% |
| 2026-06-24 | 8.84% |
| 2026-06-23 | 8.68% |
| 2026-06-22 | 8.90% |
| 2026-06-18 | 8.92% |
| 2026-06-17 | 8.67% |
| 2026-06-16 | 8.65% |
| 2026-06-15 | 8.65% |
| 2026-06-12 | 8.52% |
| 2026-06-11 | 8.55% |
| 2026-06-10 | 8.83% |
| 2026-06-09 | 8.82% |
| 2026-06-08 | 8.92% |
| 2026-06-05 | 8.77% |
| 2026-06-04 | 8.81% |
| 2026-06-03 | 9.09% |
| 2026-06-02 | 9.23% |
| 2026-06-01 | 9.17% |
| 2026-05-29 | 8.94% |
| 2026-05-28 | 8.82% |
| 2026-05-27 | 8.76% |
| 2026-05-26 | 8.77% |
| 2026-05-22 | 8.80% |
| 2026-05-21 | 8.77% |
| 2026-05-20 | 8.90% |
| 2026-05-19 | 8.85% |
| 2026-05-18 | 8.99% |
| 2026-05-15 | 9.10% |
| 2026-05-14 | 8.87% |
| 2026-05-13 | 8.87% |
| 2026-05-12 | 8.88% |
| 2026-05-11 | 9.07% |
| 2026-05-08 | 8.96% |
| 2026-05-07 | 8.94% |
| 2026-05-06 | 8.94% |
| 2026-05-05 | 8.97% |
| 2026-05-04 | 8.88% |
| 2026-05-01 | 8.76% |
| 2026-04-30 | 8.64% |
| 2026-04-29 | 8.80% |
| 2026-04-28 | 8.06% |
| 2026-04-27 | 8.10% |
| 2026-04-24 | 8.06% |
| 2026-04-23 | 7.89% |
| 2026-04-22 | 7.88% |
| 2026-04-21 | 7.82% |
| 2026-04-20 | 7.66% |
| 2026-04-17 | 7.52% |
| 2026-04-16 | 7.69% |
| 2026-04-15 | 7.59% |
| 2026-04-14 | 7.42% |
| 2026-04-13 | 7.45% |
| 2026-04-10 | 7.54% |
| 2026-04-09 | 7.52% |
| 2026-04-08 | 7.65% |
| 2026-04-07 | 7.86% |
| 2026-04-06 | 7.79% |
| 2026-04-02 | 7.75% |
| 2026-04-01 | 7.84% |
| 2026-03-31 | 7.96% |
| 2026-03-30 | 8.10% |
| 2026-03-27 | 8.15% |
| 2026-03-26 | 8.14% |
| 2026-03-25 | 8.03% |
| 2026-03-24 | 8.29% |
| 2026-03-23 | 8.45% |
| 2026-03-20 | 8.47% |
| 2026-03-19 | 8.38% |
| 2026-03-18 | 8.43% |
| 2026-03-17 | 8.22% |
| 2026-03-16 | 8.16% |
| 2026-03-13 | 8.22% |
| 2026-03-12 | 8.08% |
| 2026-03-11 | 7.96% |
| 2026-03-10 | 7.94% |
| 2026-03-09 | 7.91% |
| 2026-03-06 | 8.05% |
| 2026-03-05 | 7.94% |
| 2026-03-04 | 7.72% |
| 2026-03-03 | 7.69% |
| 2026-03-02 | 7.53% |
| 2026-02-27 | 7.42% |
| 2026-02-26 | 7.56% |
| 2026-02-25 | 7.37% |
| 2026-02-24 | 7.42% |
| 2026-02-23 | 7.41% |
| 2026-02-20 | 7.37% |
| 2026-02-19 | 7.22% |
| 2026-02-18 | 7.17% |
| 2026-02-17 | 7.21% |
| 2026-02-13 | 7.45% |
| 2026-02-12 | 7.50% |
| 2026-02-11 | 7.51% |
| 2026-02-10 | 7.46% |
| 2026-02-09 | 7.44% |
| 2026-02-06 | 7.29% |
| 2026-02-05 | 7.42% |
| 2026-02-04 | 7.67% |
| 2026-02-03 | 6.63% |
| 2026-02-02 | 6.74% |
| 2026-01-30 | 6.85% |
| 2026-01-29 | 6.98% |
| 2026-01-28 | 7.06% |
| 2026-01-27 | 6.96% |
| 2026-01-26 | 7.03% |
| 2026-01-23 | 7.19% |
| 2026-01-22 | 7.27% |
| 2026-01-21 | 7.36% |
| 2026-01-20 | 7.42% |
| 2026-01-16 | 7.33% |
| 2026-01-15 | 7.20% |
| 2026-01-14 | 6.96% |
| 2026-01-13 | 7.09% |
| 2026-01-12 | 7.02% |
| 2026-01-09 | 7.02% |
| 2026-01-08 | 7.04% |
| 2026-01-07 | 6.99% |
| 2026-01-06 | 6.99% |
| 2026-01-05 | 7.22% |
| 2026-01-02 | 7.13% |
| 2025-12-31 | 7.21% |
| 2025-12-30 | 7.17% |
| 2025-12-29 | 7.20% |
| 2025-12-26 | 7.20% |
| 2025-12-24 | 7.23% |
| 2025-12-23 | 7.24% |
| 2025-12-22 | 7.28% |
| 2025-12-19 | 7.27% |
| 2025-12-18 | 7.33% |
| 2025-12-17 | 7.26% |
| 2025-12-16 | 7.25% |
| 2025-12-15 | 7.18% |
| 2025-12-12 | 7.25% |
| 2025-12-11 | 7.24% |
| 2025-12-10 | 7.30% |
| 2025-12-09 | 7.48% |
| 2025-12-08 | 7.29% |
| 2025-12-05 | 7.30% |
| 2025-12-04 | 7.28% |
| 2025-12-03 | 7.22% |
| 2025-12-02 | 7.33% |
| 2025-12-01 | 7.50% |
| 2025-11-28 | 7.39% |
| 2025-11-26 | 7.36% |
| 2025-11-25 | 7.43% |
| 2025-11-24 | 7.52% |
| 2025-11-21 | 7.50% |
| 2025-11-20 | 7.67% |
| 2025-11-19 | 7.63% |
| 2025-11-18 | 7.47% |
| 2025-11-17 | 7.44% |
| 2025-11-14 | 7.50% |
| 2025-11-13 | 7.35% |
| 2025-11-12 | 7.36% |
| 2025-11-11 | 7.30% |
| 2025-11-10 | 7.47% |
| 2025-11-07 | 7.58% |
| 2025-11-06 | 7.51% |
| 2025-11-05 | 7.58% |
| 2025-11-04 | 7.55% |
| 2025-11-03 | 7.63% |
| 2025-10-31 | 7.55% |
| 2025-10-30 | 7.54% |
| 2025-10-29 | 7.70% |
| 2025-10-28 | 4.99% |
| 2025-10-27 | 4.98% |
| 2025-10-24 | 5.05% |
| 2025-10-23 | 4.79% |
| 2025-10-22 | 4.93% |
| 2025-10-21 | 4.97% |
| 2025-10-20 | 4.95% |
| 2025-10-17 | 4.97% |
| 2025-10-16 | 4.99% |
| 2025-10-15 | 4.98% |
| 2025-10-14 | 4.94% |
| 2025-10-13 | 4.99% |
| 2025-10-10 | 5.01% |
| 2025-10-09 | 5.02% |
| 2025-10-08 | 5.03% |
| 2025-10-07 | 5.02% |
| 2025-10-06 | 5.02% |
| 2025-10-03 | 5.03% |
| 2025-10-02 | 4.99% |
| 2025-10-01 | 4.79% |
| 2025-09-30 | 5.06% |
| 2025-09-29 | 5.31% |
| 2025-09-26 | 5.47% |
| 2025-09-25 | 5.52% |
| 2025-09-24 | 5.43% |
| 2025-09-23 | 5.39% |
| 2025-09-22 | 5.33% |
| 2025-09-19 | 5.36% |
| 2025-09-18 | 5.41% |
| 2025-09-17 | 5.41% |
| 2025-09-16 | 5.45% |
| 2025-09-15 | 5.41% |
| 2025-09-12 | 5.34% |
| 2025-09-11 | 5.26% |
| 2025-09-10 | 5.39% |
| 2025-09-09 | 5.35% |
| 2025-09-08 | 5.45% |
| 2025-09-05 | 5.39% |
| 2025-09-04 | 5.51% |
| 2025-09-03 | 5.54% |
| 2025-09-02 | 5.60% |
| 2025-08-29 | 5.50% |
| 2025-08-28 | 5.53% |
| 2025-08-27 | 5.47% |
| 2025-08-26 | 5.48% |
| 2025-08-25 | 5.50% |
| 2025-08-22 | 5.43% |
| 2025-08-21 | 5.44% |
| 2025-08-20 | 5.44% |
| 2025-08-19 | 5.51% |
| 2025-08-18 | 5.58% |
| 2025-08-15 | 5.54% |
| 2025-08-14 | 5.56% |
| 2025-08-13 | 5.57% |
| 2025-08-12 | 5.71% |
| 2025-08-11 | 5.78% |
| 2025-08-08 | 5.77% |
| 2025-08-07 | 5.80% |
| 2025-08-06 | 5.93% |
| 2025-08-05 | 5.84% |
| 2025-08-04 | 5.79% |
| 2025-08-01 | 5.81% |
| 2025-07-31 | 5.87% |
| 2025-07-30 | 5.60% |
| 2025-07-29 | 5.12% |
| 2025-07-28 | 5.15% |
| 2025-07-25 | 5.08% |
| 2025-07-24 | 5.04% |
| 2025-07-23 | 5.07% |
| 2025-07-22 | 5.21% |
| 2025-07-21 | 5.33% |
| 2025-07-18 | 5.31% |
| 2025-07-17 | 5.29% |
| 2025-07-16 | 5.04% |
| 2025-07-15 | 5.10% |
| 2025-07-14 | 5.04% |
| 2025-07-11 | 5.04% |
| 2025-07-10 | 4.87% |
| 2025-07-09 | 4.94% |
| 2025-07-08 | 5.01% |
| 2025-07-07 | 5.05% |
| 2025-07-03 | 5.05% |
| 2025-07-02 | 5.01% |
| 2025-07-01 | 4.95% |
| 2025-06-30 | 5.02% |
| 2025-06-27 | 5.00% |
| 2025-06-26 | 5.00% |
| 2025-06-25 | 5.04% |
| 2025-06-24 | 4.99% |
| 2025-06-23 | 5.04% |
| 2025-06-20 | 5.07% |
| 2025-06-18 | 4.99% |
| 2025-06-17 | 4.85% |
| 2025-06-16 | 4.76% |
| 2025-06-13 | 4.72% |
Showing the most recent 260 of 5,032 data points. The chart above shows the full history.
Related Metrics
About GSK plc
GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its extensive vaccine portfolio includes immunizations against shingles, meningitis, respiratory syncytial virus (RSV), seasonal and pandemic influenza, and polio. Beyond preventative care, GSK provides diverse therapeutic products covering critical areas such as HIV, oncology, respiratory and immunology conditions, and other specialized medical fields. This also encompasses inhaled treatments for chronic respiratory ailments like asthma and chronic obstructive pulmonary disease (COPD), along with antibiotics for various infections. Innovation at GSK is frequently driven by strategic partnerships. Notable collaborations include an agreement with CureVac to advance mRNA-based influenza vaccines, and alliances with Wave Life Sciences and Elsie Biotechnologies focused on developing oligonucleotide platforms. Furthermore, GSK has established two distinct strategic collaborations with Relation to progress therapeutics for fibrotic diseases and osteoarthritis. The company is also engaged in a multi-target strategic alliance aimed at developing pioneering treatments for individuals suffering from Parkinson's disease, and a partnership with Flagship Pioneering to identify novel medicines and vaccines.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Luke Victor Miels